May 11, 2026
Benchmarking Glycan Profiles of 209 FDA-Approved Antibodies
Why Antibody Glycosylation is So Important Therapeutic monoclonal antibodies have become one of the fastest-growing drug classes in modern biopharmaceuticals. As glycoproteins, antibodies carry a conserved N-linked glycan at position 297 (Asn297) of the Fc region. This seemingly tiny glycan structure profoundly influences the efficacy, safety, and pharmacokinetics of antibodies, including key effector functions such […]
Read More >
